当前位置:首页 - 行情中心 - 成大生物(688739) - 财务分析 - 现金流量表

成大生物

(688739)

  

流通市值:82.90亿  总市值:83.87亿
流通股本:4.12亿   总股本:4.16亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金625,029,616.15296,261,586.871,455,173,088.821,012,333,409.43
  收到的税费返还--554,299.08554,299.08
  收到其他与经营活动有关的现金9,716,097.835,949,620.7541,240,351.0532,031,729.74
  经营活动现金流入小计634,745,713.98302,211,207.621,496,967,738.951,044,919,438.25
  购买商品、接受劳务支付的现金100,910,665.0146,585,177.77293,141,344.99214,480,984.36
  支付给职工以及为职工支付的现金201,707,014.07129,815,764.75356,237,957.68280,110,219.89
  支付的各项税费88,785,978.1229,831,559.7494,843,144.4489,859,118.14
  支付其他与经营活动有关的现金172,580,310.6176,331,472.76411,880,359.34289,451,134.88
  经营活动现金流出小计563,983,967.81282,563,975.021,156,102,806.45873,901,457.27
  经营活动产生的现金流量净额70,761,746.1719,647,232.6340,864,932.5171,017,980.98
二、投资活动产生的现金流量:
  收回投资收到的现金4,276,948,573.831,380,000,0004,747,395,334.713,504,395,334.71
  取得投资收益收到的现金19,900,263.488,524,864.2127,162,732.4822,040,132.6
  处置固定资产、无形资产和其他长期资产收回的现金净额--3,432.043,500
  投资活动现金流入小计4,296,848,837.311,388,524,864.214,774,561,499.233,526,438,967.31
  购建固定资产、无形资产和其他长期资产支付的现金87,585,974.9349,592,622.29308,083,084.73251,993,518.47
  投资支付的现金4,999,000,0002,030,000,0004,593,000,0003,589,000,000
  支付其他与投资活动有关的现金32,259.3920,323.81356,995.14344,000.62
  投资活动现金流出小计5,086,618,234.322,079,612,946.14,901,440,079.873,841,337,519.09
  投资活动产生的现金流量净额-789,769,397.01-691,088,081.89-126,878,580.64-314,898,551.78
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,000,000---
  其中:子公司吸收少数股东投资收到的现金2,000,000---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计2,000,000---
  分配股利、利润或偿付利息支付的现金41,140,945.228,000329,234,779.84329,224,279.84
  支付其他与筹资活动有关的现金11,740,940.2-17,298,546.3514,264,291.73
  筹资活动现金流出小计52,881,885.428,000346,533,326.19343,488,571.57
  筹资活动产生的现金流量净额-50,881,885.4-28,000-346,533,326.19-343,488,571.57
四、汇率变动对现金及现金等价物的影响-1,429,594.44-925,002.16685,773.15970,746.96
五、现金及现金等价物净增加额-771,319,130.68-672,393,851.45-131,861,201.18-486,398,395.41
  加:期初现金及现金等价物余额4,366,190,245.614,366,190,245.614,498,051,446.794,498,051,446.79
  期末现金及现金等价物余额3,594,871,114.933,693,796,394.164,366,190,245.614,011,653,051.38
补充资料:
  净利润33,280,559.87-131,790,329.4-
  资产减值准备28,097,762.42-132,085,345.56-
  固定资产和投资性房地产折旧108,319,447.45-166,147,055.41-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧108,319,447.45-166,147,055.41-
  无形资产摊销12,686,934.03-7,470,377.59-
  长期待摊费用摊销2,069,128.26-4,138,256.52-
  处置固定资产、无形资产和其他长期资产的损失--601.76-
  固定资产报废损失34,555.29-507,215.87-
  公允价值变动损失17,834,271.66--63,167,530.34-
  财务费用1,640,428.86--80,113.26-
  投资损失-18,408,026.09--15,934,307.61-
  递延所得税-9,999,820.43-1,517,889.46-
  其中:递延所得税资产减少-9,976,551.29-1,555,345.19-
    递延所得税负债增加-23,269.14--37,455.73-
  存货的减少-5,973,309.76--52,759,125.42-
  经营性应收项目的减少-110,961,031.63-18,388,212.19-
  经营性应付项目的增加-1,039,664.08--2,714,426.02-
  其他27,659.39-127,951.14-
  现金的期末余额3,594,871,114.93-4,366,190,245.61-
  减:现金的期初余额4,366,190,245.61-4,498,051,446.79-
  现金及现金等价物的净增加额-771,319,130.68--131,861,201.18-
公告日期2026-08-252026-04-292026-04-212025-10-30
审计意见(境内)标准无保留意见
TOP↑